NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Protean BioDiagnostics

Protean BioDiagnostics

Private
Orlando, FloridaHealthcare & Life Scienceshttps://www.proteanbiodx.com/

Last Round

Debt

Sep 16, 2025

Total Funding Raised

$300,000

Company Overview

Protean BioDiagnostics is a biotechnology company that provides precision oncology diagnostic services, including digital pathology, molecular diagnostics, and AI-driven clinical trial matching for community cancer centers.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Precision Medicine, Medical AI, Clinical Trials, Healthcare Analytics

Business Model

B2B

Customer Profile

Services & Consulting, Usage-Based SaaS

AI Layer

Application

Keywords

precision oncologymolecular diagnosticsdigital pathologyliquid biopsyclinical decision supportcompanion diagnosticscancer screeningwhole exome sequencingclinical trial supportCLIA laboratoryCAP accreditationgenomic testingAI diagnosticsmedtechbiotech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Protean BioDiagnostics Comps

Public and private peers based on sector, stage, and business model.

Protean BioDiagnostics comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Protean BioDiagnostics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
DebtSep 16, 2025
AcceleratorMar 11, 2019

Key People

Founding team and executive leadership

Anthony Magliocco

President and CEO, Founder and President

Founding Team

Protean BioDiagnostics Investors

Notable investors and investment history

Protean BioDiagnostics investors
InvestorRounds
Tampa Bay Technology IncubatorAccelerator
Small Business AdministrationDebt

Protean BioDiagnostics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Protean BioDiagnostics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Protean BioDiagnostics's valuation, stock price, and market status.

Firmographic Details

HeadquartersOrlando, Florida
Employee Range9
Year Founded2017
Last FundingSep 16, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.